Post-doctoral Training Program in Cancer Metabolism and Tumor-host Interactions

癌症代谢和肿瘤宿主相互作用博士后培训项目

• 批准号: 10596510
• 负责人: Yibin Kang
• 金额: $ 29.89万
• 依托单位: RUTGERS BIOMEDICAL AND HEALTH SCIENCES
• 依托单位国家: 美国
• 财政年份: 2021
• 资助国家: 美国
• 起止时间: 2021-04-01 至 2026-03-31
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10596510
• 关键词: Training Programs; host neoplasm interaction; post-doctoral training; tumor metabolism

Rutgers Cancer Institute of New Jersey (RCINJ) provides an outstanding environment for training in basic, clinical, behavioral or population-based cancer research and brings together an exceptional group of investigators organized in multi-disciplinary research teams focusing on a broad spectrum of cancer research. The Cancer Metabolism and Growth (CMG) Program, at RCINJ has robust research strengths bolstered by strong collaboration between researchers at Rutgers and our formal consortium partner Princeton University. The proposed program leverages these unique research strengths and resources of RCINJ to provide training in translational research in Cancer Metabolism and Growth and Tumor Host Interactions. The primary goal of this T32 training program is to provide postdoctoral candidates with the highest quality training and research experience so that they are competitive in developing research careers in academia, government, and the private sector. To achieve this goal, trainees will engage in mentored cancer research, co-curricular and professional career development activities for two years. Program candidates are Ph.D. recipients who wish to develop careers in cancer research. The program will recruit a cohort of 2 new trainees each year from year 1-5. Thus, the program will have 2 trainees in year 1 and 4 trainees in year 2 through 5 of the training grant. High achieving post-doctoral fellows (evidenced by research productivity in the form of number of publications, fellowship awards, presentations etc.), may be supported for an additional third year of training through institutional funds. Faculty members with active, well-funded research programs and extensive mentoring experience will support program trainees. All of the faculty mentors chosen for this program have significant R01-level peer reviewed funding in tumor metabolism and host interactions focused research. Experienced leadership team with track-record of research productivity and mentoring will ensure successful implementation of the program. Both formative and summative evaluation will be integral parts of the proposed program. We will annually track the educational and professional activities of trainees for at least 10 years after completing research training. We will disseminate results from the comprehensive evaluation on the program website. Additional dissemination will occur through articles published in peer-reviewed journals and through presentations at regional and national conferences, by program staff as well as participants. Our program benefits from the multi-disciplinary research environment and robust educational resources available at RCINJ (the state's only NCI designated Comprehensive Cancer Center) as well as the consortium relationship with Princeton University. 19

新泽西州罗格斯癌症研究所 (RCINJ) 为基础、 临床、行为或基于人群的癌症研究，汇集了一群特殊的人 研究人员组成多学科研究团队，专注于广泛的癌症研究。 RCINJ 的癌症代谢与生长 (CMG) 项目拥有强大的研究实力， 罗格斯大学的研究人员与我们的正式联盟合作伙伴普林斯顿大学之间的密切合作。 拟议的计划利用 RCINJ 这些独特的研究优势和资源来提供培训 癌症代谢、生长和肿瘤宿主相互作用的转化研究。初级 T32培训项目的目标是为博士后候选人提供最高质量的培训和 研究经验，使他们在学术界、政府、 和私营部门。为了实现这一目标，学员将参与指导的癌症研究、课外活动 和为期两年的职业生涯发展活动。项目候选人是博士学位。收件人谁 希望在癌症研究领域发展事业。该计划每年将招募 2 名新学员 第 1-5 年。因此，该计划将在第一年有 2 名受训者，在第二年至第五年有 4 名受训者 授予。高成就的博士后研究员（以研究生产力的形式证明 出版物、奖学金、演讲等），可能会获得额外第三年培训的支持 通过机构资金。教职人员拥有积极、资金充足的研究项目和广泛的研究 指导经验将为计划受训者提供支持。所有为该项目选择的教师导师都 肿瘤代谢和宿主相互作用重点研究领域的重要 R01 级同行评审资金。 经验丰富的领导团队在研究生产力和指导方面拥有良好的记录，将确保成功 该计划的实施。形成性评价和总结性评价都将成为拟议方案的组成部分 程序。我们将每年跟踪学员的教育和专业活动至少 10 年 完成研究培训后。我们将综合评价结果予以公布 节目网站。额外的传播将通过在同行评审期刊上发表的文章和 通过计划工作人员和参与者在区域和国家会议上的演讲。我们的 该计划受益于多学科研究环境和强大的教育资源 RCINJ（该州唯一的 NCI 指定综合癌症中心）以及联盟 与普林斯顿大学的关系。 19